The Clinical Impact of Metagenomic Next-Generation Sequencing for the Diagnosis of Periprosthetic Joint Infection
Infection and Drug Resistance · 2023-10 · Volume 16 · 6521-6533
DOI: 10.2147/idr.s420325 ↗Kurz gefasst
Fallbericht in der Zeitschrift Infection and Drug Resistance, 2023-10. Verfasst von Hao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, People's Republic of China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, People's Republic of China.
- Department of Orthopedic, Chinese PLA General Hospital, Beijing, People's Republic of China.
- Department of Orthopedics, 305 Hospital of PLA, Beijing, People's Republic of China.
- School of Computer and Information Technology, Beijing Jiaotong University, Beijing, People's Republic of China.
Zitieren
APA
Li, H., Niu, E., Fu, J., Huang, Y., Gao, Y., Chai, W., & Chen, J. (2023). The Clinical Impact of Metagenomic Next-Generation Sequencing for the Diagnosis of Periprosthetic Joint Infection. Infection and Drug Resistance, Volume 16, 6521-6533. https://doi.org/10.2147/idr.s420325
Vancouver
Li H, Niu E, Fu J, Huang Y, Gao Y, Chai W, et al. The Clinical Impact of Metagenomic Next-Generation Sequencing for the Diagnosis of Periprosthetic Joint Infection. Infection and Drug Resistance. 2023;Volume 16:6521-6533. doi:10.2147/idr.s420325
BibTeX
@article{Li2023,
author = {Li, Hao and Niu, Erlong and Fu, Jun and Huang, Yinghao and Gao, Yang and Chai, Wei and Chen, Jiying},
title = {The Clinical Impact of Metagenomic Next-Generation Sequencing for the Diagnosis of Periprosthetic Joint Infection},
journal = {Infection and Drug Resistance},
year = {2023},
volume = {Volume 16},
pages = {6521--6533},
doi = {10.2147/idr.s420325}
}
EUVIMED